References
- Iung B, Baron G, Butchart EG et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur. Heart J.24(13), 1231–1243 (2003).
- Bonow RO, Carabello BA, Kanu C et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for CardiovascularxAngiography and Interventions and the Society of Thoracic Surgeons. Circulation114(5), e84–e231 (2006).
- Edwards MB, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. Ann. Thorac. Surg.75(3), 830–834 (2003).
- Malaisrie SC, McCarthy PM, McGee EC et al. Contemporary perioperative results of isolated aortic valve replacement for aortic stenosis. Ann. Thorac. Surg.89(3), 751–756 (2010).
- Cribier A, Savin T, Saoudi N et al. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet1(8472), 63–67 (1986).
- No authors listed. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation84(6), 2383–2397 (1991).
- Bernard Y, Etievent J, Mourand JL et al. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. J. Am. Coll. Cardiol.20(4), 796–801 (1992).
- Yamen E, Daniels DV, Van H, Yeung AC, Fearon WF. Use of a low-profile, compliant balloon for percutaneous aortic valvuloplasty. Catheter. Cardiovasc. Interv.75(5), 794–798 (2010).
- Cubeddu RJ, Jneid H, Don CW et al. Retrograde versus antegrade percutaneous aortic balloon valvuloplasty: immediate, short- and long-term outcome at 2 years. Catheter. Cardiovasc. Interv.74(2), 225–231 (2009).
- Eisenhauer AC, Hadjipetrou P, Piemonte TC. Balloon aortic valvuloplasty revisited: the role of the Inoue balloon and transseptal antegrade approach. Catheter. Cardiovasc. Interv.50(4), 484–491 (2000).
- Sakata Y, Syed Z, Salinger MH, Feldman T. Percutaneous balloon aortic valvuloplasty: antegrade transseptal vs. conventional retrograde transarterial approach. Catheter. Cardiovasc. Interv.64(3), 314–321 (2005).
- Daehnert I, Rotzsch C, Wiener M, Schneider P. Rapid right ventricular pacing is an alternative to adenosine in catheter interventional procedures for congenital heart disease. Heart90(9), 1047–1050 (2004).
- Witzke C, Don CW, Cubeddu RJ et al. Impact of rapid ventricular pacing during percutaneous balloon aortic valvuloplasty in patients with critical aortic stenosis: should we be using it? Catheter. Cardiovasc. Interv.75(3), 444–452 (2010).
- Pedersen WR, Van Tassel RA, Pierce TA et al. Radiation following percutaneous balloon aortic valvuloplasty to prevent restenosis (RADAR pilot trial). Catheter. Cardiovasc. Interv.68(2), 183–192 (2006).
- Spargias K, Milewski K, Debinski M et al. Drug delivery at the aortic valve tissues of healthy domestic pigs with a paclitaxel-eluting valvuloplasty balloon. J. Interv. Cardiol.22(3), 291–298 (2009).